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Abstract
Background: Causes of left atrial (LA) enlargement and its gender difference in patients with
normal left ventricular (LV) systolic function have not been clariﬁed. We investigated the factors
contributing to LA enlargement in patients with normal LV systolic function, addressing its
gender difference.
Methods: We enrolled 380 patients (175 males and 205 females; mean age: 63± 15 years) with
LV ejection fraction ≥50% who underwent Doppler echocardiography and blood tests at the
same time as echocardiography. Patients with arrhythmias, signiﬁcant valvular heart disease,
and LV asynergy were excluded. The LA volume was measured by Simpson’s method from apical
2- and 4-chamber views, and LA volume index (LAVI) was calculated as LA volume/body surface
area. All patients, male and female were assigned to a group with a low or a high LAVI based
on the median LAVI value, respectively.
Results: Age, female gender, hypertension, diabetes, hemoglobin concentration, LV mass index,
Doppler parameters of LA contraction, and the ratio of mitral early diastolic velocity to early
diastolic velocity of the mitral annulus (E/E′) were signiﬁcantly associated with a high LAVI in all
patients. Multivariate analysis showed that LV mass index [odds ratio (OR) 1.05, 95% conﬁdence
interval (CI) 1.03—1.06, P < 0.0001], hemoglobin concentration (OR 0.76, 95% CI 0.64—0.90,
P < 0.01), and female gender (OR 1.92, 95% CI 1.12—3.30, P < 0.05) independently contributed
to a high LAVI in all patients. In addition, LV mass index and hemoglobin concentration indepen-
dently contributed to a high LAVI in both genders despite the absence of overt LV hypertrophy
or anemia.
Conclusion: Increased LV wall thickness and decreased hemoglobin concentration might con-
tribute to LA enlargement in
© 2009 Japanese College of C
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IntroductionBecause left atrial (LA) enlargement is associated with prog-
nosis and cardiovascular events such as cerebral infarction
and heart failure [1,2], the importance of evaluating LA
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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ventricle. The LA volume index (LAVI) was calculated asFactors contributing to left atrial enlargement
size and causes of LA enlargement is increasing in clin-
ical practice. LA volume determined by two-dimensional
(2D) echocardiography is superior to the M-mode LA diam-
eter to assess the accurate LA size [3]. LA enlargement
is usually induced by pressure and/or volume overload,
and various factors and cardiovascular diseases are associ-
ated with LA size [4]. As examples, LA volume signiﬁcantly
differs between genders in adults without cardiovascular
disease, whereas its gender difference depends on vari-
ation in body size [5,6]. In patients with normal left
ventricular (LV) systolic function, LA volume is associ-
ated with severity of LV diastolic dysfunction and LV mass
[7,8]. However, little is known about other causes of
LA enlargement and gender difference of those in such
patients.
Therefore, we investigated the factors contributing to LA
enlargement assessed by LA volume using 2D echocardiogra-
phy in patients with normal LV systolic function, especially
addressing gender difference of those.
Methods
Study population
This cross-sectional study proceeded at Tokyo-Kita Social
Insurance Hospital and the institutional Ethics Committee
approved the study protocol. Among 2366 patients who
underwent echocardiography at our hospital between April
2006 and July 2007, we identiﬁed 1326 consecutive patients
who underwent echocardiography conducted by the same
experienced cardiac sonographer. Of these, patients ≥20
years of age, with LV ejection fraction ≥50% and who
underwent blood tests at the same time as echocardiogra-
phy were eligible for this study. Patients with a history of
arrhythmias including pacemaker implantation, LV asynergy,
signiﬁcant valvular heart disease, cardiomyopathy, congen-
ital heart disease, hemodialysis, and inadequate ultrasonic
images for evaluation were excluded. We enrolled 380 adult
patients (mean age: 63± 15 years; range, 22—91 years) who
met all of the inclusion and exclusion criteria. The study
population consisted of 205 females (54%), 264 outpatients
(69%), and 116 inpatients (31%). All patients underwent
echocardiography because of the symptoms of chest pain,
dyspnea, palpitation, dizziness and leg edema (30%),
electrocardiographic abnormalities (13%), assessment of
cardiac function for hypertension (19%), diabetes (4%),
coronary heart disease (7%), cerebral vascular disease (4%),
non-cardiac surgery (11%), and other reasons (13%).
Clinical data
We investigated whether the patients had a history of
hypertension, diabetes, congestive heart failure, coro-
nary heart disease, or taking medications for hypertension
and/or heart failure from medical records. Hypertension
was deﬁned as systolic blood pressure ≥140mmHg and/or
diastolic blood pressure ≥90mmHg, or the use of anti-
hypertensive drugs. Diabetes was deﬁned if the patients
had been diagnosed as diabetic, or were receiving anti-
diabetic treatment. Coronary heart disease was deﬁned as
a history of myocardial infarction, effort angina, coronary
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pastic angina, silent myocardial ischemia, and coronary
evascularization such as percutaneous coronary interven-
ion and/or bypass graft surgery. Patients were enrolled
f hemoglobin concentrations and serum creatinine lev-
ls had been measured within 3 days before or after
chocardiography.
chocardiography
chocardiography was performed by one experienced car-
iac sonographer (H.O.) using the same echocardiographic
nstrument (Toshiba Aplio SSA-700A, Toshiba, Otawara,
apan) ﬁtted with a 2.5-MHz transducer. The following
arameters were examined in M-mode with the paraster-
al long-axis view: LA diameter, LV diameter in end diastole
LVDd) and LV diameter in end systole (LVDs), fractional
hortening, interventricular septal thickness (IVST), poste-
ior wall thickness (PWT), and LV mass [9]. The LV mass
ndex was calculated as LV mass/body surface area. The LV
jection fraction was measured using the Teichholz M-mode
ethod. The infra vena cava diameter was also measured at
nd expiration in the epigastric view.
Both LV diastolic function and valvular heart disease
ere assessed by Doppler echocardiography. Transmitral
ow velocity curve was recorded using pulsed wave Doppler
chocardiography in the apical 3-chamber view. Early dias-
olic mitral inﬂow velocity (E), late diastolic mitral inﬂow
elocity (A), the deceleration time of the E wave (DT),
he E/A ratio, and duration of A wave (Ad) were mea-
ured. Pulmonary venous ﬂow velocity curve was recorded
sing pulsed wave Doppler echocardiography in the apical
-chamber view. Systolic forward ﬂow velocity (S), diastolic
orward ﬂow velocity (D), atrial reversal ﬂow velocity (AR),
nd duration of the AR wave (ARd) were measured. The dif-
erence between the ARd and Ad (ARd−Ad) was calculated.
issue Doppler imaging of the septal mitral annulus was
ecorded in the apical 4-chamber view. The early diastolic
elocity (E′) and late diastolic velocity (A′) were measured,
nd the ratios of E′ to A′ (E′/A′) and E to E′ (E/E′) were
alculated.
The severity of valvular regurgitation was semi-
uantitatively evaluated by the distance of the color Doppler
et, and the grade of regurgitation was deﬁned as trace,
ild, moderate, and severe. Patients with valvular regurgi-
ation≥mild grade, valvular stenosis, and prosthetic valves
n any valves were excluded from this study due to hav-
ng clinically signiﬁcant valvular heart disease. In addition,
atients with mitral annulus calciﬁcation were excluded if
he mitral valve area measured by the pressure half time
ethod using mitral inﬂow early velocity was ≤2 cm2.
A cardiologist unaware of patients’ clinical background
easured LA volume using the modiﬁed Simpson’s method
9]. Maximum LA areas except for the conﬂuence of pul-
onary veins and the left atrial appendage were traced in
pical 2- and 4-chamber views at end systole of the leftA volume/body surface area. To assess the intraobserver
nd interobserver variability in measurement of LAVI, 10
atients were randomly selected and measured by main
bserver at two separate occasions and another independent
bserver.
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Table 1 Clinical characteristics.
All patients (n = 380) Male (n = 175) Female (n = 205) P-value
Age (years) 63± 15 62± 15 64± 14 NS
Body surface area (m2) 1.6± 0.2 1.7± 0.2 1.5± 0.1 <0.0001
Body mass index (kg/m2) 23.5± 3.5 23.6± 3.3 23.3± 3.6 NS
Hypertension (%) 54 53 56 NS
Diabetes (%) 19 20 18 NS
History of CHD (%) 5 8 2 <0.01
History of CHF (%) 1 3 0 <0.05
Medications (%) 41 39 42 NS
ACEI 5 5 5 NS
ARB 22 19 26 NS
ACEI/ARB 27 23 30 NS
CCB 28 27 29 NS
-Blocker 8 9 8 NS
Diuretics 3 4 3 NS
Serum creatinine (mg/dl) 0.8± 0.4 0.9± 0.4 0.7± 0.2 <0.0001
Hemoglobin (g/dl) 13.4± 1.7 14.1± 1.8 12.8± 1.5 <0.0001
Data are mean± standard deviation (SD) or percentage of patients. P-values were calculated by comparison between men and women.
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pNS, not signiﬁcant; CHD, coronary heart disease; CHF, congestiv
angiotensin II receptor blocker; CCB, calcium-channel blocker.
tatistical analysis
ata are expressed as numbers and percentages for categori-
al variables, andmeans± standard deviation for continuous
ariables. Correlations between continuous variables and
AVI were examined using Spearman’s correlation analysis.
atients were assigned based on the median LAVI to either
he low or the high (≤ or >median LAVI) group. Two groups
ere compared using Fisher’s exact test or Mann—Whitney’s
-test. Independent contributing factors to the LAVI were
nvestigated by multiple logistic regression analysis of sig-
iﬁcant variables in the univariate analysis. Variables that
trongly inﬂuenced others were excluded from the multi-
ariate analysis. Male and female were compared using each
nalysis. A P-value <0.05 was considered signiﬁcant. All data
ere analyzed using Stat-View software (version 5.0, SAS
nstitute Inc., Cary, NC, USA).
esults
linical characteristics and echocardiographic
easurements
he clinical characteristics of the patients, of whom over
alf had hypertension and about 40% were administered
ith anti-hypertensive and/or diuretic drugs, are pre-
ented in Table 1. The proportions of coronary heart
isease and congestive heart failure, serum creatinine
evel, and hemoglobin concentration were signiﬁcantly
igher among males than females. Echocardiographic mea-
urements (Table 2) revealed mean LAV and LAVI values
f 54± 14ml and 35± 9ml/m2, respectively. Regarding
eproducibility in measurement of LAVI, intraobserver
nd interobserver variability were 1.0± 1.3ml/m2 and
t
(
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c
trt failure; ACEI, angiotensin-converting enzyme inhibitor; ARB,
.1± 2.2ml/m2, respectively. Although the LAV was simi-
ar between males and females, the LAVI was signiﬁcantly
igher in females than inmales. The LVDd, LVDs and variables
egarding LV wall thickness (IVST, PWT, LV mass, and LV mass
ndex) were signiﬁcantly higher in males than in females. On
he other hand, diastolic parameters such as A, ARd−Ad,
nd E/E′ were signiﬁcantly higher in females than in males.
orrelations of continuous variables with LAVI
s shown in Table 3, age and hemoglobin concentration sig-
iﬁcantly correlated with LAVI, whereas body mass index
nd serum creatinine level did not. Echocardiographic ﬁnd-
ngs showed that variables associated with LV wall thickness
nd LA contraction (peak A velocity, E/A ratio, duration of
wave, and duration of pulmonary venous AR wave) closely
orrelated with LAVI. Of the tissue Doppler parameters, E′/A′
nd E/E′ ratios were correlated with LAVI because of the
egative correlation between E′ and LAVI. The results were
imilar for both genders to those for all patients, but E/E′
id not signiﬁcantly correlate with LAVI in men. We show the
catter plots of LV mass index and hemoglobin concentration
or LAVI in all patients (Fig. 1).
omparison of groups with low and high LAVI
ata from the groups with low and high median LAVI
alues are presented in Tables 4 and 5. Overall, the
atients were older, and the proportions of women, hyper-
ension, diabetes, and history of anti-hypertensive drugs
rennin—angiotensin system inhibitors and calcium-channel
lockers) were signiﬁcantly higher, whereas the hemoglobin
oncentration was signiﬁcantly lower in the high, than in
he low LAVI group. Body mass index and serum creatinine
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Table 2 Echocardiographic measurements.
All patients (n = 380) Male (n = 175) Female (n = 205) P-value
LA diameter (mm) 40 ± 5 40 ± 5 40 ± 6 NS
LA volume (ml) 54 ± 14 54 ± 13 53 ± 15 NS
LAVI (ml/m2) 35 ± 9 33 ± 8 37 ± 10 <0.01
LVDd (mm) 47 ± 5 49 ± 4 46 ± 4 <0.0001
LVDs (mm) 31 ± 4 32 ± 4 30 ± 4 <0.0001
LVEF (%) 65 ± 5 64 ± 5 66 ± 5 <0.0001
FS (%) 36 ± 4 35 ± 4 36 ± 4 <0.0001
IVST (mm) 9 ± 2 10 ± 1 9 ± 2 <0.0001
PWT (mm) 9 ± 1 9 ± 1 9 ± 1 <0.0001
LV mass (g) 149 ± 38 164 ± 37 137 ± 36 <0.0001
LV mass index (g/m2) 96 ± 23 99 ± 22 93 ± 23 <0.01
IVC diameter (mm) 14 ± 3 14 ± 3 14 ± 3 NS
E (cm/s) 74 ± 16 71 ± 15 75 ± 17 NS
A (cm/s) 78 ± 16 75 ± 20 80 ± 22 <0.05
Ad (ms) 151 ± 20 152 ± 21 150 ± 19 NS
E/A 1.0 ± 0.5 1.0 ± 0.4 1.0 ± 0.5 NS
DT (ms) 234 ± 51 237 ± 53 232 ± 50 NS
S (cm/s) 66 ± 14 66 ± 16 66 ± 13 NS
D (cm/s) 44 ± 11 44 ± 11 44 ± 11 NS
S/D 1.6 ± 0.5 1.6 ± 0.5 1.5 ± 0.4 NS
AR (cm/s) 32 ± 10 32 ± 10 32 ± 9 NS
ARd (ms) 137 ± 25 134 ± 23 140 ± 27 NS
ARd−Ad (ms) −13 ± 28 −18 ± 27 −10 ± 29 <0.05
E′ (cm/s) 7 ± 3 7 ± 2 7 ± 3 NS
A′ (cm/s) 10 ± 2 10 ± 2 10 ± 2 NS
E′/A′ 0.7 ± 0.3 0.7 ± 0.3 0.7 ± 0.3 NS
E/E′ 11 ± 3 10 ± 3 11 ± 4 <0.05
Data are mean± standard deviation (SD). P-values were calculated by comparison between male and female. LA, left atrial; LV, left
ventricular; VI, volume index; Dd, diameter in end diastole; Ds, diameter in end systole; EF, ejection fraction; FS, fractional shortening;
IVST, interventricular septal thickness; PWT, posterior wall thickness; IVC, inferior vena cava; E, peak early diastolic mitral inﬂow
velocity; A, peak late diastolic mitral inﬂow velocity; Ad, duration of late diastolic mitral inﬂow wave; DT, deceleration time; S, peak
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wpulmonary venous systolic forward ﬂow velocity; D, peak pulmona
atrial reversal ﬂow velocity; ARd, duration of pulmonary venous a
annulus; A′, peak late diastolic velocity of the septal annulus.
levels were similar between the two groups. These results
were similar to those found in females. The proportions of
diabetics and those taking medications did not signiﬁcantly
differ among males between the groups (Table 4).
The echocardiographic parameters (Table 5) showed that
LVDd and variables regarding LV wall thickness were signif-
icantly higher in the high, than in the low LAVI group. In
addition, LA contraction (peak A velocity, E/A ratio, dura-
tion of A wave, and of pulmonary venous AR wave) and low E′
velocity (E′/A′ and E/E′) signiﬁcantly differed between the
groups. These results were similar for both genders.
Multivariate analysis
The results of multiple logistic regression analysis of the
variables with P-values <0.01 in a comparison of the low
and high LAVI groups are presented in Table 6. The LV mass
index, hemoglobin concentration, and female gender were
independently related to high LAVI, whereas age, hyperten-
sion, and E/E′ were not. The LV mass index and hemoglobin
concentration were independently related to a high LAVI for
the same variables for each gender.
T
p
L
i
inous diastolic forward ﬂow velocity; AR, peak pulmonary venous
reversal ﬂow wave; E′, peak early diastolic velocity of the septal
iscussion
he present study demonstrated that LV mass index,
emoglobin concentration, and female gender were inde-
endently associated with LA enlargement assessed by
AVI in patients with normal systolic LV function. In addi-
ion, LV mass index and hemoglobin concentration also
ndependently contributed to LA enlargement in both
enders.
V mass index and LAVI
revious studies already showed the relationship between LV
ass index and LAVI [7,8,10,11]; however, the considerable
esult in the present study was that mean LV mass index
as within the normal range even in the high LAVI group.
siouﬁs et al. [10] also showed that LV mass index was inde-
endently associated with LAVI in hypertensive patients with
V mass index in the normal range. Increased LV mass index
s related to increased LV stiffness and elevation of LV ﬁll-
ng pressure, which induce LA enlargement [12]. Considering
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Table 3 Correlation of clinical and echocardiographic variables with left atrial volume index.
All patients Male Female
 P-value  P-value  P-value
Age 0.29 <0.0001 0.20 <0.01 0.35 <0.0001
Body surface area −0.18 <0.01 −0.18 <0.05 −0.04 NS
Body mass index 0.08 NS 0.01 NS 0.17 <0.05
Serum creatinine −0.05 NS 0.10 0.21 0.05 NS
Hemoglobin −0.35 <0.0001 −0.28 <0.01 −0.32 <0.0001
LA diameter 0.53 <0.0001 0.35 <0.0001 0.68 <0.0001
LVDd 0.13 <0.05 0.20 <0.05 0.15 <0.05
LVDs 0.06 NS 0.20 <0.01 0.02 NS
LV ejection fraction 0.12 <0.05 −0.07 NS 0.22 <0.05
Fractional shortening 0.13 <0.05 −0.06 NS 0.02 NS
IVST 0.34 <0.0001 0.23 <0.01 0.53 <0.0001
PWT 0.28 <0.0001 0.20 <0.01 0.46 <0.0001
LV mass 0.35 <0.0001 0.35 <0.0001 0.55 <0.0001
LV mass index 0.49 <0.0001 0.45 <0.0001 0.58 <0.0001
IVC diameter 0.03 NS 0.11 NS 0.04 NS
E 0.09 NS −0.01 NS 0.13 NS
A 0.26 <0.0001 0.10 NS 0.34 <0.0001
E/A −0.17 <0.01 −0.13 NS −0.18 <0.05
DT 0.02 NS 0.02 NS 0.05 NS
Ad 0.17 <0.01 0.24 <0.01 0.15 <0.05
S 0.03 NS −0.05 NS 0.09 NS
D −0.08 NS −0.01 NS −0.16 <0.05
S/D 0.11 <0.05 0.02 NS 0.19 <0.01
AR −0.04 NS −0.01 NS −0.09 NS
ARd 0.22 <0.0001 0.23 NS 0.18 <0.05
ARd−Ad 0.06 NS 0.03 NS 0.02 NS
E′ −0.30 <0.0001 −0.20 <0.01 −0.36 <0.0001
A′ −0.07 NS 0.01 NS −0.14 <0.05
E′/A′ −0.21 <0.0001 −0.21 <0.01 −0.21 <0.01
E/E′ 0.34 <0.0001 0.14 NS 0.46 <0.0001
LA, left atrial; LV, left ventricular; Dd, diameter in end diastole; Ds, diameter in end systole; IVST, interventricular septal thickness;
PWT, posterior wall thickness; IVC, inferior vena cava; E, peak early diastolic mitral inﬂow velocity; A, peak late diastolic mitral inﬂow
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ur results and other results, it is suggested that this mech-
nism is already developed even in the absence of overt LV
ypertrophy.
Although hypertension is the most common etiology for
n increased LV mass index, it was not an independent con-
ributing factor to a high LAVI in the multivariate analysis.
ome studies also showed that LV mass index was the bet-
er predictive factor for the increase of LAVI compared with
lood pressure levels [10,11]. We postulate that increased LV
ass affects more directly left atrium through the elevation
f LV ﬁlling pressure compared with hypertension.
emoglobin concentration and LAVInotable ﬁnding in the present study is the signiﬁcant nega-
ive correlation between hemoglobin concentration and LAVI
rrespective of gender, although mean hemoglobin concen-
ration in each gender was almost within the normal range.
hronic anemia is known to induce cardiac dilatation caused
W
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L
o
dw wave; S, peak pulmonary venous systolic forward ﬂow velocity;
ulmonary venous atrial reversal ﬂow velocity; ARd, duration of
ocity of the septal annulus; A′, peak late diastolic velocity of the
y high cardiac output, and even cardiac hypertrophy in an
xperimental rat model [13] and humans [14]. Few data are
vailable showing that hemoglobin concentration is directly
elated to LAVI in patients with hemoglobin concentration
ithin the normal range. However, possible explanations for
he result are that lower hematocrit or hemoglobin concen-
ration has been shown to be associated with increased LV
ass or diastolic dysfunction, even in the absence of overt
nemia [14,15]. Then, both LV mass index and diastolic dys-
unction represented by E/E′ were related to LAVI as shown
n the present study.
ender difference and LAVIe found that female gender was independently related
o a high LAVI. In contrast, a few studies have shown that
A volume is higher in males than females in adults with-
ut cardiovascular diseases [5,6]; however, the difference
iminished when LA volume was indexed by body surface
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Table 4 Comparison between low and high LAVI groups on clinical characteristics.
All patients Male Female
Low LAVI
(n = 190)
High LAVI
(n = 190)
P-value Low LAVI
(n = 88)
High LAVI
(n = 87)
P-value Low LAVI
(n = 103)
High LAVI
(n = 102)
P-value
Age (years) 60± 15 66± 14 <0.0001 59± 15 64± 15 <0.05 61± 15 68 ±13 <0.01
Gender (female; %) 47 61 <0.01 NA NA NA NA NA NA
Body surface area (m2) 1.6± 0.2 1.5± 0.2 <0.01 1.7± 0.2 1.6± 0.2 NS 1.5± 0.1 1.5± 0.1 NS
Body mass index (kg/m2) 23.3± 3.3 23.7± 3.6 NS 23.7± 3.2 23.5± 3.3 NS 22.8± 3.4 24.0± 3.8 <0.01
Hypertension (%) 46 63 <0.01 43 62 <0.05 43 69 <0.01
Diabetes (%) 13 24 <0.01 15 25 NS 8 27 <0.01
History of CHD (%) 6 4 NS 8 8 NS 1 3 NS
History of CHF (%) 1 2 NS 2 3 NS 0 0 NS
Medications (%) 33 48 <0.01 33 45 NS 32 53 <0.01
ACEI 4 6 NS 3 6 NS 5 6 NS
ARB 17 29 <0.01 14 25 NS 17 34 <0.01
ACEI/ARB 20 34 <0.01 9 30 NS 21 39 <0.01
CCB 21 35 <0.01 23 31 NS 18 39 <0.01
Blocker 6 11 NS 7 10 NS 6 11 NS
Diuretics 2 5 NS 2 6 NS 1 5 NS
Serum creatinine (mg/dl) 0.8± 0.4 0.8± 0.4 NS 0.9± 0.5 0.9± 0.4 NS 0.6± 0.1 0.7± 0.3 NS
Hemoglobin (g/dl) 13.9± 1.6 12.9± 1.7 <0.0001 14.5± 1.6 13.6± 1.8 <0.01 13.2± 1.4 12.5± 1.4 <0.01
Data are mean± standard deviation (SD) or percentage of patients. P-values were calculated by comparison between low and high LAVI groups. LAVI, left atrial volume index; NA, not
available; CHD, coronary heart disease; CHF, congestive heart failure; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium-channel blocker.
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Table 5 Comparison between low and high LAVI groups on echocardiographic measurements.
All patients Male Female
Low LAVI
(n = 190)
High LAVI
(n = 190)
P-value Low LAVI
(n = 88)
High LAVI
(n = 87)
P-value Low LAVI
(n = 103)
High LAVI
(n = 102)
P-value
LA diameter (mm) 38 ± 5 42 ± 5 <0.0001 39 ± 4 41 ± 5 <0.01 37 ± 5 44 ± 5 <0.0001
LA volume (ml) 45 ± 7 68 ± 11 <0.0001 45 ± 7 64 ± 11 <0.0001 42 ± 7 65 ± 12 <0.0001
LAVI (ml/m2) 28 ± 4 42 ± 8 <0.0001 27 ± 4 39 ± 6 <0.0001 29 ± 4 44 ± 9 <0.0001
LVDd (mm) 47 ± 5 48 ± 4 <0.05 48 ± 5 49 ± 4 NS 46 ± 4 47 ± 4 <0.05
LVDs (mm) 31 ± 5 31 ± 4 NS 31 ± 8 33 ± 4 <0.05 30 ± 4 30 ± 4 NS
LVEF (%) 65 ± 5 65 ± 5 NS 64 ± 5 63 ± 5 NS 65 ± 5 66 ± 5 <0.05
FS (%) 35 ± 4 36 ± 4 NS 35 ± 4 34 ± 3 NS 36 ± 4 37 ± 4 <0.05
IVST (mm) 9 ± 1 10 ± 2 <0.0001 9 ± 1 10 ± 2 <0.05 8 ± 1 10 ± 2 <0.0001
PWT (mm) 9 ± 1 9 ± 2 <0.0001 9 ± 1 10 ± 1 <0.05 8 ± 1 9 ± 2 <0.0001
LV mass (g) 138 ± 36 161 ± 37 <0.0001 154 ± 35 174 ± 36 <0.01 121 ± 29 153 ± 35 <0.0001
LV mass index (g/m2) 87 ± 18 105 ± 23 <0.0001 91 ± 17 107 ± 23 <0.0001 83 ± 18 104 ± 23 <0.0001
IVC diameter (mm) 14 ± 3 14 ± 3 NS 14 ± 3 14 ± 3 NS 13 ± 3 13 ± 3 NS
E (cm/s) 73 ± 15 74 ± 18 NS 72 ± 13 71 ± 17 NS 74 ± 16 77 ± 18 NS
A (cm/s) 73 ± 20 82 ± 21 <0.01 72 ± 19 77 ± 21 NS 74 ± 22 86 ± 21 <0.01
Ad (ms) 148 ± 19 153 ± 20 <0.05 148 ± 20 156 ± 21 <0.01 148 ± 19 151 ± 18 NS
E/A 1.1 ± 0.5 1.0 ± 0.4 <0.01 1.1 ± 0.5 1.0 ± 0.4 NS 1.1 ± 0.6 1.0 ± 0.3 <0.05
DT (ms) 233 ± 50 235 ± 53 NS 233 ± 50 241 ± 56 NS 230 ± 49 233 ± 52 NS
S (cm/s) 66 ± 14 66 ± 14 NS 66 ± 16 66 ± 16 NS 65 ± 13 67 ± 13 NS
D (cm/s) 45 ± 11 43 ± 11 NS 44 ± 10 44 ± 12 NS 45 ± 11 43 ± 11 NS
S/D 1.6 ± 0.4 1.5 ± 0.5 NS 1.6 ± 0.5 1.6 ± 0.5 NS 1.5 ± 0.5 1.6 ± 0.3 NS
AR (cm/s) 32 ± 11 31 ± 9 NS 31 ± 12 32 ± 9 NS 33 ± 10 31 ± 9 NS
ARd (ms) 134 ± 23 141 ± 27 <0.01 129 ± 18 139 ± 25 <0.01 137 ± 25 142 ± 29 NS
ARd−Ad (ms) −14 ± 26 −12 ± 30 NS −19 ± 24 −16 ± 29 NS −10 ± 28 −9 ± 29 NS
E′ (cm/s) 8 ± 3 7 ± 2 <0.0001 8 ± 2 7 ± 2 <0.05 8 ± 3 7 ± 3 <0.0001
A′ (cm/s) 10 ± 2 10 ± 2 NS 10 ± 2 10 ± 2 NS 10 ± 2 10 ± 2 NS
E′/A′ 0.8 ± 0.4 0.7 ± 0.3 <0.01 0.8 ± 0.3 0.7 ± 0.3 <0.01 0.8 ± 0.4 0.7 ± 0.3 <0.05
E/E′ 10 ± 3 12 ± 3 <0.0001 10 ± 3 11 ± 3 NS 10 ± 3 13 ± 4 <0.0001
Data are mean± standard deviation (SD). P-values were calculated by comparison between low and high LAVI groups. LA, left atrial; VI, volume index; LV, left ventricular; Dd, diameter in
end diastole; Ds, diameter in end systole; EF, ejection fraction; FS, fractional shortening; IVST, interventricular septal thickness; PWT, posterior wall thickness; IVC, inferior vena cava; E,
peak early diastolic mitral inﬂow velocity; A, peak late diastolic mitral inﬂow velocity; Ad, duration of late diastolic mitral inﬂow wave; DT, deceleration time; S, peak pulmonary venous
systolic forward ﬂow velocity; D, peak pulmonary venous diastolic forward ﬂow velocity; AR, peak pulmonary venous atrial reversal ﬂow velocity; ARd, duration of pulmonary venous atrial
reversal ﬂow wave; E′, peak early diastolic velocity of the septal annulus; A′, peak late diastolic velocity of the septal annulus.
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Table 6 Multiple logistic regression analysis to predict high left atrial volume index.
All patients Male Female
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Age 0.99 0.98—1.02 NS 0.99 0.97—1.03 NS 0.99 0.96—1.02 NS
Gender (female) 1.92 1.12—3.30 <0.05 NA NA NA NA NA NA
Hypertension 0.95 0.56—1.62 NS 1.15 0.53—2.49 NS 0.87 0.41—1.85 NS
Diabetes 1.13 0.59—2.15 NS 0.76 0.31—1.85 NS 1.99 0.71—5.61 NS
Hemoglobin 0.76 0.64—0.90 <0.01 0.74 0.59—0.95 <0.05 0.77 0.60—0.99 <0.05
LV mass index 1.05 1.03—1.06 <0.0001 1.04 1.02—1.06 <0.01 1.06 1.03—1.08 <0.0001
′ 1
ot sig
i
L
a
[
a
tE/E 1.08 0.99—1.18 NS 1.0
OR, odds ratio; CI, conﬁdence interval; LV, left ventricular; NS, n
velocity; E′, peak early diastolic velocity of the septal annulus.
area [4,6]. The difference between the studies is that
our study population included patients with cardiovascu-
lar diseases, whereas we could not sufﬁciently explain the
relationship between female gender and a high LAVI.Diastolic function and LAVI
E/E′ is more closely correlated than conventional diastolic
parameters with mean LV diastolic pressure [16]. Two stud-
Figure 1 Scatter plots of left ventricular mass index (left
panel) and hemoglobin concentration (right panel) for left atrial
volume index in all patients. LAVI, left atrial volume index; LV,
left ventricular; Hb, hemoglobin.
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f0.88—1.16 NS 1.14 0.99—1.29 NS
niﬁcant; NA, not available; E, peak early diastolic mitral inﬂow
es showed that LV diastolic dysfunction was associated with
AVI [7,8]; whereas Pritchett et al. reported that LAVI is not
robust marker of mild or moderate diastolic dysfunction
8]. Here, E′ and E/E′ were signiﬁcantly correlated with LAVI
mong LV diastolic parameters in the univariate, but not in
he multivariate analysis. This ﬁnding indicated that some
actors such as LV mass index, hemoglobin concentration,
nd gender difference were more strongly associated with
A enlargement than diastolic function represented by E/E′
n the present study. In addition, several patients with mild
o moderate diastolic dysfunction might have been included
n the present study, because E/A was negatively correlated
ith LAVI.
tudy limitations
lthough associations were demonstrated between LAVI and
few factors, we could not prove any cause-and-effect rela-
ionships using this cross-sectional design.
Moreover, the mean LAVI of 35ml/m2 in the present study
as considerably higher than that in other studies [8,17].
amaguchi et al. [17] reported that mean LAVI measured
y the biplane Simpson’s method is 22ml/m2 and that mean
AVI + 2SD is 30ml/m2 in normal Japanese adults with amean
ge of 39 years. The discrepancy in LAVI values is partly
xplained by the inclusion of elderly patients with cardio-
ascular diseases in the present study. The accuracy of LA
rea planimetry might be limited because the left atrium
as located in the far ﬁeld of the apical view [9].
Finally, selection bias might have affected our results
ecause we enrolled only patients who underwent blood
ests at the same time as echocardiography.
onclusions
ncreased LV wall thickness and decreased hemoglobin con-
entration may contribute to LA enlargement in patients
ith normal LV systolic function irrespective of gender.
oreover, it is suggested that these parameters affect LA
ize even in the absence of overt LV hypertrophy or anemia.cknowledgments
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